1.

Does IP₆ reduce calcium, iron, zinc or other minerals?

No!This has been a long-held misconception that was based on some not-so-rigorous studies in the 1950's whereby mineral deficiency in certain populations in Egypt and northern Iran was associated with eating unleavened bread which is rich in IP₆. However, these 'studies' did not consider other factors that may have been associated with mineral deficiencies. Subsequent carefully designed studies both in humans and in laboratory animals in different laboratories world-wide have refuted this misconception. More recently, in a study of 412 infants in the Western Highlands of Guatemala, interestingly neither zinc supplementation nor IP₆-reduced maize nor their combination enhanced the growth of 6- to 12-month-old Guatemalan infants (Journal of Nutrition 2010) pointing to the fallacy; had dietary IP₆ and resultant zinc deficiency been responsible for their stunted growth, the infants should have been cured! One factor that may contribute to the confusion is the chemical state of the molecule. In nature IP₆ exists as a salt of Ca⁺⁺ and Mg⁺⁺ i.e. calcium-magnesium inositol hexaphosphate (also known as phytin, please see below).

However, for experimental purposes, many other different salts of IP₆ are available. The negatively charged molecule inositol hexaphosphoric acid (without the cations, also known as phytic acid) which does not exist in nature will of course bind to cations in the test tube. As a matter of fact, a very important mechanism of action of IP₆ is it's property as an antioxidant which is mediated by chelating iron as demonstrated in the test-tube. Yet, here is the conundrum: life-time experiments in rodents and recent human studies have not shown a mineral deficiency following oral administration of IP₆ salts even though the ions presumably dissociate in vivo!

2.

Why combine Inositol with IP₆?

The scientific premise has been that the addition of inositol to IP₆ in a 1:1 molar raio would yield more of the lower inositol phosphate, IP₃ (Ins 1,4,5 P₃ is the most active isomer) a key regulator in cell, thereby increasing the efficiency of IP₆. Indeed experiments have proven that the combination has resulted in synergistic, most consistent and safe anti-cancer, and immune enhancing effect.  

From the safety + efficacy point of view, while both inositol and IP₆ independently show anti-cancer action, their effects are however variable in different models and species. In some models, IP₆-alone though reduced the overall tumor incidence, alarmingly it had increased the size of the tumors in the animals that did not respond to it. The anti-cancer effect of Inositol in vivo is relatively week (in vitro it does not have anti-cancer action as it is an essential compound for culturing cells in the lab). However, when all the various tumor parameters (tumor number, tumor burden, incidence etc) were taken into account, the combination of IP₆+Inositol was the safest and the most effective (please consult Table 1 in page 1056 of the original paper in the Journal "Carcinogenesis" 1995 volume 16 and other related papers). Thus, based on the available lab data, for safety and efficacy, human clinical trials must include the combination of IP₆ + Inositol and NOT IP₆ alone.

The stack bar graph shows cumulative data on tumor prevalence, tumor volume and tumor frequency in mice treated with IP₆ ± Inositol following induction of colon cancer by the chemical DMH. Note that in this model IP₆ treatment (second from left) did not change the size of the tumors, whereas inositol did (chocolate colored). Note that when all the 3 parameters are considered together, the combination of IP₆ + Inositol yielded the best result, that was statistically significant.

Measurement of NK (natural killer) cell activity in these animals show that the NK activity is reduced in cancer (compare with the tap water control). Both IP₆ and Inositol boost NK activity, the results being similar (contrast that with data above). However, the increased NK activity by the combination of IP₆ + Inositol in tumor bearing animals is even higher than the tap water control; more spectacular is the marked boosting in normal healthy animals that did not receive the carcinogen.                         

3.

What is the source of IP₆ and Inositol?

The two main sources of reagent-grade IP₆ and Inostiol are rice (rice-bran) and corn. Most of the nutraceutical-grade compounds are extracted from rice bran. The purity of Inositol is >99.8%; however due to the complex and tedious nature of extraction and purification, hence cost, while the reagent-grade IP₆ is about 98% pure, that of nutraceutical grade range from 50-92%. Of course the purer the compound, the more efficient, and even more importantly safe it is; over a certain level of purity the cost becomes exorbitant.

4.

Does IP₆ and inositol interact with other medicine or food?

Inositol is very inert and is not known to have any interaction. IP₆ owing to its chemical structure of having 6 phosphate groups, is suspected to be reactive. However, the naturally occuring IP₆ is in the form of calcium-magnesium IP₆ whereby the reactive phosphates are unavailable for any strong chemical interaction.  

Both experimentally and clinically IP₆ + Inositol have been found to act synergistically with standard chemotherapeutic drugs. Please go to "What's New" page for details.

As to platelets, IP₆ causes an inhibition of platelet aggregation which is one of the earliest steps in clotting within blood vessels. It appears that "IP₆ is about 2-fold more potent than aspirin in inhibiting platelet aggregation." Thus the two have similar action insofar as platelet aggregation is concerned.  

For more detailed information please consult the book by Dr Shamsuddin